New RSV shot shows promise for vulnerable babies
NCT ID NCT06042049
First seen Apr 26, 2026 · Last updated May 22, 2026 · Updated 5 times
Summary
This study tested a medicine called nirsevimab in 33 Japanese infants under 1 year old who are at high risk for severe RSV infection due to heart or lung problems, weak immune systems, Down syndrome, or premature birth. The goal was to check safety and how the body responds to two doses given 5 to 6 months apart. The study found that the treatment was generally safe and helped produce antibodies against RSV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Bunkyō City, 113-8519, Japan
-
Research Site
Fuchu-shi, 183-8561, Japan
-
Research Site
Fukuoka, 813-0017, Japan
-
Research Site
Kitakyusyu-shi, 806-8501, Japan
-
Research Site
Kōtoku, 135-8577, Japan
-
Research Site
Kurume-shi, 830-0011, Japan
-
Research Site
Nagasaki, 852-8501, Japan
-
Research Site
Saitama-shi, 336-8522, Japan
-
Research Site
Yokohama, 232 8555, Japan
Conditions
Explore the condition pages connected to this study.